Fortress Biotech, Inc. (FBIO): Price and Financial Metrics


Fortress Biotech, Inc. (FBIO): $0.84

-0.05 (-6.13%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add FBIO to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

FBIO POWR Grades


  • FBIO scores best on the Growth dimension, with a Growth rank ahead of 94.66% of US stocks.
  • The strongest trend for FBIO is in Sentiment, which has been heading down over the past 179 days.
  • FBIO ranks lowest in Quality; there it ranks in the 4th percentile.

FBIO Stock Summary

  • Of note is the ratio of Fortress Biotech Inc's sales and general administrative expense to its total operating expenses; merely 18.52% of US stocks have a lower such ratio.
  • With a year-over-year growth in debt of -24.96%, Fortress Biotech Inc's debt growth rate surpasses only 16.51% of about US stocks.
  • Revenue growth over the past 12 months for Fortress Biotech Inc comes in at 50.86%, a number that bests 81.79% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Fortress Biotech Inc, a group of peers worth examining would be TVTX, RDCM, CLVS, ARDX, and APM.
  • FBIO's SEC filings can be seen here. And to visit Fortress Biotech Inc's official web site, go to www.fortressbiotech.com.

FBIO Valuation Summary

  • In comparison to the median Healthcare stock, FBIO's price/sales ratio is 44.49% lower, now standing at 6.3.
  • FBIO's price/earnings ratio has moved down 2.3 over the prior 119 months.
  • FBIO's price/sales ratio has moved NA NA over the prior 119 months.

Below are key valuation metrics over time for FBIO.

Stock Date P/S P/B P/E EV/EBIT
FBIO 2021-08-31 6.3 3.1 -10.0 -7.0
FBIO 2021-08-30 6.2 3.0 -9.9 -6.8
FBIO 2021-08-27 6.2 3.0 -9.9 -6.8
FBIO 2021-08-26 5.9 2.9 -9.4 -5.9
FBIO 2021-08-25 6.2 3.0 -9.8 -6.6
FBIO 2021-08-24 6.2 3.0 -9.9 -6.7

FBIO Growth Metrics

    The 2 year net cashflow from operations growth rate now stands at 9.85%.
  • Its 5 year net cashflow from operations growth rate is now at -294.84%.
  • The 2 year price growth rate now stands at -29.03%.
Over the past 52 weeks, FBIO's revenue has gone up $21,284,000.

The table below shows FBIO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 64.264 -98.33 -38.433
2021-06-30 52.654 -100.526 -33.199
2021-03-31 44.268 -83.478 -42.978
2020-12-31 45.599 -83.682 -46.526
2020-12-31 45.599 -83.682 -46.526
2020-09-30 42.98 -88.248 -56.723

FBIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • FBIO has a Quality Grade of D, ranking ahead of 14.81% of graded US stocks.
  • FBIO's asset turnover comes in at 0.147 -- ranking 224th of 682 Pharmaceutical Products stocks.
  • MGNX, MTEX, and MNKKQ are the stocks whose asset turnover ratios are most correlated with FBIO.

The table below shows FBIO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.147 0.638 -0.159
2021-03-31 0.138 0.668 -0.248
2020-12-31 0.163 0.680 -0.265
2020-12-31 0.163 0.680 -0.265
2020-09-30 0.169 0.677 -0.339
2020-06-30 0.183 0.695 -0.332

FBIO Price Target

For more insight on analysts targets of FBIO, see our FBIO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $10.17 Average Broker Recommendation 1.5 (Moderate Buy)

FBIO Stock Price Chart Interactive Chart >

Price chart for FBIO

FBIO Price/Volume Stats

Current price $0.84 52-week high $4.49
Prev. close $0.89 52-week low $0.79
Day low $0.82 Volume 401,600
Day high $0.93 Avg. volume 549,055
50-day MA $1.14 Dividend yield N/A
200-day MA $2.31 Market Cap 89.83M

Fortress Biotech, Inc. (FBIO) Company Bio


Fortress Biotech, Inc., a biopharmaceutical company, develops novel immunotherapy agents for the treatment of autoimmune diseases and cancer. The company was founded in 2006 and is based in New York, New York.


FBIO Latest News Stream


Event/Time News Detail
Loading, please wait...

FBIO Latest Social Stream


Loading social stream, please wait...

View Full FBIO Social Stream

Latest FBIO News From Around the Web

Below are the latest news stories about Fortress Biotech Inc that investors may wish to consider to help them evaluate FBIO as an investment opportunity.

Mustang Bio Announces City of Hope MB-105 Prostate Stem Cell Antigen CAR T Data Selected for Presentation at the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium

WORCESTER, Mass., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that City of Hope Phase 1 clinical trial data on MB-105, a prostate stem cell antigen (“PSCA”) chimeric antigen receptor (“CAR”) T-cell therapy administered systemically to pati

Yahoo | February 15, 2022

QBREXZA® (Rapifort® Wipes 2.5%) Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Milestone Payment to Journey Medical Corporation

SCOTTSDALE, Ariz., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions, today announced that it received notice from its exclusive licensing partner in Japan, Maruho Co., Ltd. (“Maruho”), that Japan's Ministry of Health, Labor and Welfare (“MHLW”) approved Rapifort® Wipes 2.5% (glyco

Yahoo | February 11, 2022

Mustang Bio Selected as a Bronze Winner in Eighteenth Annual Team Massachusetts Economic Impact Awards

WORCESTER, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced the company was selected as the Bronze winner for the Central region in the Eighteenth Annual Team Massachusetts Economic Impact Awards presented by MassEcon. The awards honor c

Yahoo | February 8, 2022

Fortress Biotech to Participate in the 2nd Annual Winter Wonderland Best Ideas Virtual Investor Conference

MIAMI, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative revenue-generating company focused on acquiring, developing and commercializing or monetizing promising biopharmaceutical products and product candidates cost-effectively, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will present a corporate update at the 2nd Annual Winter Wonderland Best Ideas Virtual Investor Conference on Wednesday, Fe

Yahoo | February 7, 2022

36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022

RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th \- 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.The virtual conference begins on Tuesday, February 8th, 2022, with company presentations beginning at 8:30 am Eastern Time.

Yahoo | January 28, 2022

Read More 'FBIO' Stories Here

FBIO Price Returns

1-mo -20.75%
3-mo -50.59%
6-mo -70.32%
1-year -77.05%
3-year -54.59%
5-year -78.73%
YTD -66.40%
2021 -21.14%
2020 23.35%
2019 198.84%
2018 -78.45%
2017 47.78%

Continue Researching FBIO

Here are a few links from around the web to help you further your research on Fortress Biotech Inc's stock as an investment opportunity:

Fortress Biotech Inc (FBIO) Stock Price | Nasdaq
Fortress Biotech Inc (FBIO) Stock Quote, History and News - Yahoo Finance
Fortress Biotech Inc (FBIO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7807 seconds.